About Mitera Biosciences
Mitera Biosciences is a private company based in Bellevue, Washington. It has reported $2,845,000 raised in two offerings on Form D since May 2024. Its chief executive is Kevin Chow.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Apr 21, 2026 | May 6, 2026 | $1,100,000of $3.0M target | 2 | $550K | Options, Securities on exercise, Simple Agreement for Future EquityRule 506(b) | Form D ↗ |
| Apr 24, 2024 | May 9, 2024amended Dec 22, 2025 | $1,745,000of $2.0M target | 6 | $290K | Options, Securities on exercise, Simple Agreement for Future EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Total, two offerings | $2,845,000 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Mitera Biosciences's Form D filed May 6, 2026.
